Decarbonization And US Supply Chains Will Generate Future Momentum

Key Takeaways

• Strategic investments in U.S. battery materials and premium product portfolios position LG Chem to capture market share and margin growth amid global electrification and supply chain shifts.
  
• Enhanced R&D, targeted M&As, and cost optimization in both chemicals and life sciences underpin earnings stability and support long-term growth in high-value, resilient sectors.
  
• Diminished EV demand, regulatory hurdles, declining petrochemical volumes, and heavy capital spending threaten LG Chem's margins, cash flow, and financial flexibility.

Catalysts

Engages in the petrochemicals, energy, advanced materials, and life science businesses in Korea, China, Asia/Oceania, the United States, Europe, and internationally.

• The ongoing global push towards decarbonization and electrification, including policies supporting EV penetration and green technologies, remains a long-term tailwind for LG Chem's battery materials and eco-friendly products. Despite temporary headwinds from subsidy phaseouts, preparations for production ramp-up in North America in 2026 and new supply contracts (e.g., with Toyota) signal a pathway to renewed volume growth and margin recovery in the medium term, positively affecting future revenue and earnings.
  
• The shift by OEMs towards non-China supply chains and the tightening of regulations around sourcing for EV batteries create a significant opportunity for LG Chem's U.S.-based cathode plant and vertically integrated value chain. As customers seek local and non-China supply, LG Chem's early investments position it to capture both market share and price premiums, supporting higher revenue and improved net margins.
  
• The focus on expanding the high-value portfolio (e.g., premium ABS, synthetic rubber, specialty chemicals) and active restructuring of commodity and intermediate operations aligns with industry trends favoring high-performance and sustainable materials, which is expected to lift blended margins and drive more resilient earnings as demand for basic petrochemical products moderates.
  
• Accelerating R&D efforts and targeted M&As in Life Sciences, with a focus on areas like oncology, immunology, and advanced pharmaceutical candidates, tap into the growing global healthcare needs and aging populations, supporting long-term revenue growth, stable milestone income, and a higher contribution from high-margin specialty businesses.
  
• The company's ongoing optimization of operations, cost reduction initiatives, active portfolio rebalancing, and prudent use of asset proceeds (e.g., from business divestitures) bolster financial flexibility and cash flow. This enables continued investment in growth engines and support for shareholder returns, positioning LG Chem for enhanced earnings stability and capital deployment in a transforming industry landscape.

LG Chem Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• Analysts are assuming LG Chem's revenue will grow by 14.2% annually over the next 3 years.
• Analysts assume that profit margins will increase from -6.0% today to 7.1% in 3 years time.
• Analysts expect earnings to reach ₩4833.3 billion (and earnings per share of ₩42884.42) by about June 2029, up from -₩2716.5 billion today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting ₩7072.1 billion in earnings, and the most bearish expecting ₩1826.6 billion.
• In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 11.5x on those 2029 earnings, up from -10.5x today. This future PE is lower than the current PE for the KR Chemicals industry at 13.5x.
• Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 9.49%, as per the Simply Wall St company report.

Risks

• Weakening demand for EVs in the U.S. driven by the sunset of IRA subsidies, lifting of fuel efficiency regulations, and new tariffs is expected to cause a contraction in LG Chem's cathode materials business through 2025, leading to reduced shipments and worsening profitability, directly impacting revenues and net margins.
  
• Persistently cautious inventory management by major customers and project delays in the battery materials segment point to near-term volume declines and loss-making quarters, suggesting that earnings volatility may remain elevated until at least 2026.
  
• Ongoing tariff disputes (U.S.-Korea reciprocal tariffs, IRA content restrictions) as well as increasing regulatory barriers (PFE regulations) raise structural costs and could erode LG Chem's cost competitiveness in key segments, creating sustained margin pressure.
  
• Petrochemical demand outlook remains muted as global overcapacity, China's uncertain restructuring policy, and ongoing U.S. tariff barriers combine to hold down product volumes and limit recovery potential, thereby weighing on overall cash flow and profitability.
  
• Large capital expenditure requirements for plant construction (e.g., U.S. cathode plant, bio oil ecosystem) and a continued shift toward high-value/high-growth segments may strain free cash flow, increasing reliance on asset sales or borrowings, which could weaken balance sheet stability and limit shareholder distributions.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The analysts have a consensus price target of ₩441640.0 for LG Chem based on their expectations of its future earnings growth, profit margins and other risk factors.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ₩540000.0, and the most bearish reporting a price target of just ₩298000.0.
• In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be ₩67847.5 billion, earnings will come to ₩4833.3 billion, and it would be trading on a PE ratio of 11.5x, assuming you use a discount rate of 9.5%.
• Given the current share price of ₩363500.0, the analyst price target of ₩441640.0 is 17.7% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.